Compass Pathways Shares Slide as Market Weakness and Clinical Binary Loom
Compass Pathways stock dropped sharply in afternoon trading as a broad selloff hit high-volatility biotech names and investors positioned for a binary COMP006 26-week Part B durability data readout expected in early Q3 2026. Despite prior gains that pushed the shares near a 52-week high, no new company-specific news was cited for the decline, which…